56 research outputs found
“Swapping” Families: Serial Parenting and Economic Support for Children
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71408/1/j.1741-3737.2000.00111.x.pd
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
BACKGROUND: The safety and efficacy of the AZD1222 (ChAdOx1 nCoV-19) vaccine in a large, diverse population at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States, Chile, and Peru has not been known.
METHODS: In this ongoing, double-blind, randomized, placebo-controlled, phase 3 clinical trial, we investigated the safety, vaccine efficacy, and immunogenicity of two doses of AZD1222 as compared with placebo in preventing the onset of symptomatic and severe coronavirus disease 2019 (Covid-19) 15 days or more after the second dose in adults, including older adults, in the United States, Chile, and Peru.
RESULTS: A total of 32,451 participants underwent randomization, in a 2:1 ratio, to receive AZD1222 (21,635 participants) or placebo (10,816 participants). AZD1222 was safe, with low incidences of serious and medically attended adverse events and adverse events of special interest; the incidences were similar to those observed in the placebo group. Solicited local and systemic reactions were generally mild or moderate in both groups. Overall estimated vaccine efficacy was 74.0% (95% confidence interval [CI], 65.3 to 80.5; P
CONCLUSIONS: AZD1222 was safe and efficacious in preventing symptomatic and severe Covid-19 across diverse populations that included older adults. (Funded by AstraZeneca and others; ClinicalTrials.gov number, NCT04516746.)
Phase Transitions and Second-Harmonic Generation in Sodium Monothiophosphate
Oxythiophosphate compounds, which contain anions comprised
of oxidized phosphorus bound to oxygen and sulfur, are scarce
and, in general, poorly characterized. Although α-Na3PO3S has
been known for over 60 years, little has been revealed about this
compound. Here we present thermal analysis and second-harmonic-generation (SHG) efficiency of α-Na3PO3S. Details about
its transformation to the high-temperature β phase are discussed.
Under vacuum, α-Na3PO3S undergoes one endothermic event at
553 °C upon heating and two exothermic events at 504 and 467
°C upon cooling. β-Na3PO3S can be trapped upon quenching
Na3PO3S from high temperature. We have observed that the β
phase converts back to the α phase at room temperature.
Interestingly, relative humidity has been determined to catalyze
this phase transformation. α-Na3PO3S oxidizes at 315 °C in air to
produce Na4P2O7 and Na2SO4. Upon exposure to 1064-nm incident
radiation, noncentrosymmetric α-Na3PO3S produces an SHG
efficiency 200 times that of α-quartz and is nonphase-matchable
(type 1)
ChemInform Abstract: A Simple Aqueous Metathesis Reaction Yields New Lanthanide Monothiophosphates.
A Single Dose Monoclonal Antibody Immunoprophylaxis Strategy to Prevent Respiratory Syncytial Virus Disease in All Infants: Results of the First in Infant Study with medi8897
Investigation of the Effect of NiO Nanoparticles on the Transport Properties of Zr<SUB>0.5</SUB>Hf<SUB>0.5</SUB>Ni<SUB>1–<I>x</I></SUB>Pd<SUB><I>x</I></SUB>Sn<SUB>0.99</SUB>Sb<SUB>0.01</SUB> (<I>x</I> = 0 and 0.2)
A Passive Vaccine Approach to Respiratory Syncytial Virus Prophylaxis for All Infants: Results of a Phase 1 Study in Healthy Adult Volunteers
Structure–property relationships along the Fe-substituted CuInS2 series: Tuning of thermoelectric and magnetic properties
Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants
- …
